20 . March , 2019 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Nicotine

Big Image Pronouncation: (NIK-oh-TEEN)
Class: Smoking deterrent

Trade Names:
- Lozenges 2 mg
- Lozenges 4 mg

Trade Names:
- Transdermal system 17.5 mg
- Transdermal system 35 mg
- Transdermal system 52.5 mg

Trade Names:
- Transdermal system 36 mg
- Transdermal system 78 mg
- Transdermal system 114 mg

Trade Names:
- Chewing gum 2 mg/square

Trade Names:
Nicorette DS
- Chewing gum 4 mg/square

Trade Names:
- Transdermal system 8.3 mg
- Transdermal system 16.6 mg
- Transdermal system 24.9 mg

Trade Names:
Nicotrol NS
- Spray pump 0.5 mg nicotine/actuation

Trade Names:
Nicotrol Inhaler
- Inhaler 4 mg delivered (10 mg/cartridge)

Trade Names:
- Transdermal system 15 mg
- Transdermal system 30 mg

Nicorette Plus (Canada)

Mechanism of Action


Reduces nicotine withdrawal symptoms by providing nicotine levels lower than those associated with smoking.

Indications and Usage

Aid to smoking cessation. Part of comprehensive behavioral smoking-cessation program.


Nonsmokers; during immediate post-MI period; life-threatening arrhythmias; severe or worsening angina pectoris; active temporomandibular joint disease (nicotine polacrilex gum).

Dosage and Administration

Advise patient to stop smoking completely when beginning to use smoking cessation therapy.

Nicotine Gum

PO If patient smokes less than 25 cigarettes/day, chew 2 mg gum (max, 24 pieces/day) for up to 12 wk. If patient smokes at least 25 cigarettes/day, chew 4 mg gum (max, 24 pieces/day) for up to 12 wk.

Nicotine Lozenges

PO If patient smokes first cigarette more than 30 min after waking up, start with the 2 mg lozenge. If patient smokes first cigarette within 30 min after waking up, start with the 4 mg lozenge. Week 1 to 6, slowly dissolve 1 lozenge in the mouth q 1 to 2 hr; week 7 to 9, slowly dissolve 1 lozenge in the mouth q 2 to 4 hr; week 10 to 12, slowly dissolve 1 lozenge in the mouth q 4 to 8 hr.

Nicotine Inhaler

Inhaler 6 to 16 cartridges/day for up to 6 mo.

Nicotine Transdermal Patches
Adults Habitrol

Topical If patient smokes at least 10 cigarettes/day, start with 21 mg/day for first 4 wk, then decrease dose to 14 mg/day for next 2 wk, then decrease dose to 7 mg/day for last 2 wk. If patient smokes less than 10 cigarettes/day, start with 14 mg/day for 6 wk then decrease dose to 7 mg/day for last 2 wk.


Topical If patient smokes at least 10 cigarettes/day, start with 21 mg/day for first 6 wk then decrease dose to 14 mg/day for next 2 wk, then decrease dose to 7 mg/day for last 2 wk. If patient smokes less than 10 cigarettes/day, start with 14 mg/day for 6 wk then decrease dose to 7 mg/day for last 2 wk.


Topical Use 15 mg/16 hr for 6 wk.

Nicotine Nasal Spray

Spray (Each actuation delivers 50 mcL spray containing 0.5 mg nicotine.) 8 to 40 doses/day for 3 to 6 mo.

General Advice

  • Inhalation system
  • Have patient continuously puff on mouthpiece (approximately 20 minutes).
  • Discard used container in safe place.
  • Store mouthpiece in plastic case between uses.
  • Clean mouthpiece regularly with soap and water.
  • Lozenge
  • Place lozenge in mouth and allow to slowly dissolve (20 to 30 minutes) while occasionally moving the lozenge from one side of the mouth to the other.
  • Do not chew or swallow lozenge.
  • Do not eat or drink 15 minutes before using or while lozenge is in mouth.
  • Nicotine chewing gum
  • Instruct patient to chew gum 1 piece at a time.
  • Tell patient to chew intermittently for about 30 min.
  • Do not allow patient to eat or drink for 15 min before chewing and during chewing.
  • Transdermal system
  • Apply patch promptly on removal from pouch.
  • Apply patch once daily to clean, dry skin site on upper body or upper outer arm.
  • After patch has been on for 24 hr, remove and apply new patch to alternate skin site. Do not reuse skin sites for at least 1 wk (exception is Nicotrol , which is applied on awakening and removed at bedtime).
  • After handling active patch, wash hands with water alone. Do not touch eyes.
  • After removing used patch from skin, fold over, place in protective pouch, and immediately dispose of it so that it is inaccessible to children and pets.


Inhalation system

Store cartridge at 77°F or below. Protect from light.


Store at controlled room temperature (68° to 77°F). Protect from light.

Nicotine chewing gum

Store at controlled room temperature (68° to 77°F). Protect from light.

Transdermal system

Store at controlled room temperature (68° to 77°F). Do not store out of pouch.

Drug Interactions

Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propanolol, theophylline

Smoking tends to increase metabolism and may lower blood levels of these drugs or others. Smoking cessation, with or without nicotine medication, may reverse these effects.


Effective absorption of nicotine gum depends on mildly alkaline saliva. Coffee, cola, and other drinks or food may reduce salivary pH and should probably be avoided 15 min before and during chewing of gum.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Edema; flushing; hypertension; palpitations; tachyarrhythmias; tachycardia; MI; CHF; cardiac arrest; cerebrovascular accident.


Insomnia; dizziness; lightheadedness; irritability; headache; impaired concentration; confusion; convulsions; depression; paresthesia; abnormal dreams.


Erythema; rash; itching; urticaria.


Buccal cavity irritation; mouth or throat soreness or dryness. With gum chewing: traumatic injury to oral mucosa or teeth; jaw ache; changes in taste perception.


GI distress; belching; indigestion; nausea; vomiting; excess salivation; hiccoughs; anorexia; constipation; diarrhea.


Alterations of LFTs.


Increased cough; pharyngitis; sinusitis; difficulty breathing; hoarseness; sneezing.


Pain; myalgia; arthralgia; dysmenorrhea.



Category C (nicotine polacrilex gum); Category D (inhaler, spray, transdermal nicotine).


Excreted in breast milk.


Safety and efficacy not established.


May be more susceptible to adverse effects.

Hepatic Function

Hepatic impairment may reduce nicotine clearance.


Transference of nicotine dependence from smoking to deterrent product exists. If patient continues to smoke while on nicotine therapy, severe effects caused by higher nicotine levels may be experienced.

Cardiovascular effects

Patients with coronary heart disease, serious cardiac arrhythmias, systemic hypertension, or vasospastic disease need to be carefully evaluated and monitored closely because of cardiac effects.

Debilitated patients

May be more susceptible to adverse effects.

Dental problems

Might be exacerbated by chewing nicotine gum.

Endocrine effects

Use with caution in patients with hyperthyroidism, pheochromocytoma, or insulin-dependent diabetes because of action of nicotine on adrenal medulla.

GI effects

May delay healing in patients with peptic ulcer disease.



Nausea, salivation, abdominal pain, vomiting, diarrhea, cold sweat, headache, dizziness, disturbed hearing and vision, mental confusion, marked weakness, faintness, prostration, hypotension, difficult breathing, rapid, weak, irregular pulse, respiratory collapse.

Patient Information

  • Review package insert information with patient.
  • Inform patient of serious effects if continuing to smoke while chewing gum or using patch. Instruct patient to stop smoking. Encourage patient to participate in comprehensive smoking cessation program.
  • Warn patient of possible dependence of medication.
  • Tell patient that gum or patch is not for long-term use and that dose will be gradually tapered off over course of a few weeks to a month.
  • Inform patient it will take a few days to adjust to taste of gum.
  • Instruct patient to avoid drinking or eating 15 min before and during chewing of gum.
  • Advise patient to chew gum slowly 1 piece at a time when urge to start smoking is felt.
  • Instruct patient regarding proper use of gum (intermittent technique of slow-paced chewing and “parking”).
  • Advise patient not to exceed 30 pieces of gum/day (2 mg size) or 20 pieces/day (4 mg size) and to decrease this number gradually over first month.
  • Tell patient to inspect mouth daily (if chewing gum) for signs of irritation.
  • Instruct patient in proper use and disposal of patch. Tell patient to always remove old patch before applying new one, and to wash hands after applying patch.
  • Advise patient regarding proper storage of patch (eg, heat sensitive, rapid evaporation once opened).
  • Instruct patient to report the following symptoms to health care provider: GI distress (ie, constipation, diarrhea, nausea), headache, depression, dizziness, hiccoughs, sore throat or pain, or mouth discomfort.
  • Nasal spray
  • Encourage patient to participate in a smoking cessation program.
  • If the patient has not stopped smoking by the fourth week of therapy, discontinue treatment.

Recent Drug Updates at DrugIndexOnline:

Anti-Thymocyte Globulin (Rabbit) Anti-Thymocyte Globulin (Rabbit)
Generic Name: Anti-Thymocyte Globulin (Rabbit) (AN-tye THYE-moe-site GLOB-yoo-lin) Brand Name: ThymoglobulinAnti-Thymocyte Globulin (Rabbit) should only be given by a doctor in a medical setting under the supervision of a doctor who is experienced in management of organ transplant patients. Ant more...

Extra Strength Maalox GRF Gas Relief Formula Extra Strength Maalox GRF Gas Relief Formula
Some commonly used brand names are: In the U.S.— Extra Strength Maalox Anti-Gas Flatulex Gas Relief Gas-X Gas-X Extra Strength Genasyme Maalox Anti-Gas Maximum Strength Gas Relief Maximum Strength Mylanta Gas Relief Maximum Strength Phazyme My Baby Gas Relief Drops Mylanta Gas Mylanta Gas more...

Metyrapone Metyrapone
Generic Name: Metyrapone (me-TEER-a-pone) Brand Name: MetopironeMetyrapone is used for:Testing pituitary function. Metyrapone is a diagnostic aid. It works by blocking the body's natural production of cortisol and corticosterone. This causes the pituitary gland to increase production of cortic more...

metyrosine metyrosine
Generic Name: metyrosine (me TYE roe seen) Brand Names: Demser What is metyrosine? Metyrosine is used to treat pheochromocytoma. It is used before surgery to control pheochromocytoma, as well as to treat the disease when surgery is not possible. Metyrosine may also be used for purposes o more...

Nitrofurazone Topical Nitrofurazone Topical
Some commonly used brand names are: In the U.S.— Furacin Cream Furacin Soluble Dressing Furacin Topical Solution Category Antibacterial (topical) Description Nitrofurazone (nye-tro-FYOOR-a-zone) is used to treat burns that have become infected. It is also used to treat skin infec more...

Novantrone injectable Novantrone injectable
Generic Name: mitoxantrone (injectable) (mye toe ZAN trone) Brand Names: Novantrone What is mitoxantrone? Mitoxantrone is a cancer (antineoplastic) medication. Mitoxantrone interferes with the growth of cancer cells and slows their growth and spread in the body. Mitoxantrone also affects more...

Praziquantel Praziquantel
Generic Name: Praziquantel (pray-zi-KWON-tel) Brand Name: BiltricidePraziquantel is used for:Treating certain worm infections (eg, schistosoma, liver flukes). Praziquantel is an anthelmintic agent. It works by killing sensitive worms. Do NOT use Praziquantel if: you are allergic to any ingred more...

Pred-G ophthalmic ointment Pred-G ophthalmic ointment
Generic Name: gentamicin sulfate and prednisolone acetate Dosage Form: Ophthalmic ointment sterile Pred-G® sterile ophthalmic ointment is a topical anti-inflammatory/anti-infective combination product for ophthalmic use. Structural Formulas: Chemical Names: Prednisolone acetate: 11ß more...